Caricamento...
In vitro modeling of COPD inflammation and limitation of p38 inhibitor – SB203580
BACKGROUND: Systemic inflammation and steroid resistance are the hallmarks of COPD. We examined the impact of p38 inhibitor (SB203580) in in vitro assays of systemic inflammation using pulmonary cells and patients’ sera. OBJECTIVE AND METHODS: Data from 66 COPD patients and 15 age-/sex-matched healt...
Salvato in:
| Pubblicato in: | Int J Chron Obstruct Pulmon Dis |
|---|---|
| Autori principali: | , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Dove Medical Press
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4857829/ https://ncbi.nlm.nih.gov/pubmed/27199554 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S99810 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|